NCT07025239 QL1706 Injection Plus Bevacizumab and XELOX vs Placebo Plus Bevacizumab and XELOX as First-Line Treatment of Unresectable Metastatic Colorectal Cancer Status NOT_YET_RECRUITING Phase PHASE3
NCT07024615 A Study of ASP2138 Given Before Surgery, Then Chemotherapy After Surgery, in People With Pancreatic Ductal Cancer Status RECRUITING Phase PHASE1
NCT07018570 An Open Label Phase 2 Study of Total Neoadjuvant Therapy (TNT) Consisting of FLOT With Pembrolizumab and Short Radiation for Patients With Locally Advanced Gastroesophageal Junction Adenocarcinoma Status RECRUITING Phase PHASE2
NCT07018063 Neoadjuvant Nab-Paclitaxel Plus Oxaliplatin, S-1, and Sintilimab in Early-Onset Resectable Gastric Cancer Status NOT_YET_RECRUITING Phase PHASE2
NCT06998771 JSKN003 Combined Treatment of HER2-positive Gastric Cancer Status NOT_YET_RECRUITING Phase PHASE2
NCT06997497 A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012) Status RECRUITING Phase PHASE3
NCT06990516 SHR - A1811 Injection in the Treatment of Platinum-sensitive Recurrent Ovarian Cancer Status NOT_YET_RECRUITING Phase PHASE1/PHASE2
NCT06963502 A Phase Ib Study of HS-10370 in Addition to Other Anti-cancer Therapies in Patients With Advanced Solid Tumors Status NOT_YET_RECRUITING Phase PHASE1
NCT06958328 Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer Status RECRUITING Phase PHASE3
NCT06951503 AK112 and Chemotherapy in First-line Metastatic Colorectal Cancer Status RECRUITING Phase PHASE3
NCT06948448 A Study to Evaluate the Safety and Efficacy of Two Dose Levels of ONO-4578 With Opdivo®, in Combination With mFOLFOX6 and Bevacizumab Versus Standard of Care in Participants With Non-MSI-H/dMMR, PD-L1 Positive Advanced Colorectal Cancer Status RECRUITING Phase PHASE2
NCT06941857 NC410 and FOLFIRINOX in Combination With Nivolumab With or Without Ipilimumab in Patients With Untreated Metastatic Pancreatic Cancer Status RECRUITING Phase PHASE2
NCT06928584 Hypofractionated Radiotherapy Plus Immunotherapy Versus Conventional Radiotherapy in Locally Recurrent Rectal Cancer Status RECRUITING Phase PHASE2
NCT06914687 Efficacy of Tirellizumab Combined With Oral, Intravenous and Abdominal Chemotherapy in Peritoneal Metastatic Gastric/Gastroesophageal Junction Adenocarcinoma Status NOT_YET_RECRUITING Phase PHASE2
NCT06905509 Epcoritamab Plus Standard of Care Platinum-Based Chemotherapy and Autologous Hematopoietic Cell Transplant for the Treatment of Relapsed or Refractory Large B-cell Lymphoma Status RECRUITING Phase PHASE2
NCT06901531 A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer Status RECRUITING Phase PHASE3
NCT06897644 Gemcitabine Plus Nab-paclitaxel as Switch Maintenance Versus Continuation of Modified FOLFIRINOX as 1st Line Chemotherapy in Patients With Advanced Pancreatic Cancer. Status RECRUITING Phase PHASE3
NCT06894797 Preoperative Chemoradiotherapy Combined With Consolidation or Induction NALIRIFOX in Rectal Cancer. Status RECRUITING Phase NA
NCT06888843 Study to Evaluate the Use of Capecitabine in Monotherapy and in Combination With Oxaliplatin in Elderly Patients as Adjuvant Chemotherapy for Locally Advanced Colorectal Cancer. Status RECRUITING Phase PHASE2
NCT06885385 A Phase 2 Study Evaluating the Safety and Efficacy of JS207 With or Without JS015 in Combination With Chemotherapy in Patients With Colorectal Cancer Status RECRUITING Phase PHASE2